XML 36 R16.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
INCOME TAXES

5. INCOME TAXES

The provision for income taxes consists of the following (in millions):

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Current:

 

 

 

 

 

 

 

 

 

Federal

 

$

149

 

 

$

 

 

$

(46

)

State

 

 

7

 

 

 

5

 

 

 

6

 

 

 

156

 

 

 

5

 

 

 

(40

)

Deferred:

 

 

 

 

 

 

 

 

 

Federal

 

 

(5

)

 

 

166

 

 

 

161

 

State

 

 

40

 

 

 

(1

)

 

 

10

 

 

 

35

 

 

 

165

 

 

 

171

 

Total provision for income taxes for income

 

$

191

 

 

$

170

 

 

$

131

 

 

The following table reconciles the differences between the statutory federal income tax rate and the effective tax rate (dollars in millions):

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

 

 

Amount

 

 

%

 

 

Amount

 

 

%

 

 

Amount

 

 

%

 

Provision for income taxes at statutory
  federal rate

 

$

44

 

 

 

21.0

%

 

$

73

 

 

 

21.0

%

 

$

105

 

 

 

21.0

%

State income taxes, net of federal income tax benefit

 

 

37

 

 

 

17.9

 

 

 

3

 

 

 

0.8

 

 

 

44

 

 

 

8.7

 

Net income attributable to noncontrolling interests

 

 

(31

)

 

 

(14.9

)

 

 

(28

)

 

 

(8.0

)

 

 

(29

)

 

 

(5.8

)

Change in valuation allowance

 

 

88

 

 

 

42.5

 

 

 

122

 

 

 

34.9

 

 

 

33

 

 

 

6.8

 

Change in uncertain tax position

 

 

10

 

 

 

4.9

 

 

 

 

 

 

 

 

 

 

 

 

 

Nondeductible goodwill

 

 

29

 

 

 

14.1

 

 

 

 

 

 

 

 

 

 

 

 

 

Amended return adjustments

 

 

9

 

 

 

4.3

 

 

 

 

 

 

 

 

 

(22

)

 

 

(4.4

)

Other

 

 

5

 

 

 

2.5

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes and
  effective tax rate for income

 

$

191

 

 

 

92.3

%

 

$

170

 

 

 

48.7

%

 

$

131

 

 

 

26.3

%

 

The Company’s effective tax rates were 92.3%, 48.7% and 26.3% for the years ended December 31, 2023, 2022 and 2021, respectively. The increase in the Company’s effective tax rate for the year ended December 31, 2023, when compared to the year ended December 31, 2022, was primarily due to non-deductible goodwill related to hospitals divested in 2023 and a decrease in income before taxes. The increase in the Company’s effective tax rate for the year ended December 31, 2022, when compared to the year ended December 31, 2021, was primarily due to an increase in non-deductible interest for 2022 compared to 2021, compounded by an adverse change in the IRC Section 163(j) limit for deductible interest expense beginning in 2022.

Deferred income taxes are based on the estimated future tax effects of differences between the financial statement and tax bases of assets and liabilities under the provisions of the enacted tax laws. Deferred income taxes as of December 31, 2023 and 2022 consist of (in millions):

 

 

 

December 31,

 

 

 

2023

 

 

2022

 

 

 

Assets

 

 

Liabilities

 

 

Assets

 

 

Liabilities

 

Net operating loss and credit carryforwards

 

$

533

 

 

$

 

 

$

553

 

 

$

 

Property and equipment

 

 

 

 

 

326

 

 

 

 

 

 

323

 

Self-insurance liabilities

 

 

16

 

 

 

 

 

 

30

 

 

 

 

Prepaid expenses

 

 

 

 

 

30

 

 

 

 

 

 

31

 

Intangibles

 

 

 

 

 

163

 

 

 

 

 

 

148

 

Investments in unconsolidated affiliates

 

 

 

 

 

72

 

 

 

 

 

 

58

 

Other liabilities

 

 

 

 

 

7

 

 

 

 

 

 

9

 

Long-term debt and interest

 

 

32

 

 

 

 

 

 

41

 

 

 

 

Accounts receivable

 

 

16

 

 

 

 

 

 

16

 

 

 

 

IRC Section 163(j) interest limitation

 

 

582

 

 

 

 

 

 

448

 

 

 

 

Accrued vacation

 

 

19

 

 

 

 

 

 

19

 

 

 

 

Accrued bonus

 

 

27

 

 

 

 

 

 

19

 

 

 

 

Other comprehensive income

 

 

4

 

 

 

 

 

 

6

 

 

 

 

Right-of-use assets

 

 

 

 

 

165

 

 

 

 

 

 

148

 

Right-of-use liability

 

 

173

 

 

 

 

 

 

156

 

 

 

 

Stock-based compensation

 

 

4

 

 

 

 

 

 

5

 

 

 

 

Deferred compensation

 

 

38

 

 

 

 

 

 

51

 

 

 

 

IRC Section 481(a) adjustments

 

 

 

 

 

57

 

 

 

 

 

 

122

 

Other

 

 

19

 

 

 

 

 

 

19

 

 

 

 

Total

 

 

1,463

 

 

 

820

 

 

 

1,363

 

 

 

839

 

Valuation allowance

 

 

(983

)

 

 

 

 

 

(829

)

 

 

 

Total deferred income taxes

 

$

480

 

 

$

820

 

 

$

534

 

 

$

839

 

 

The Company believes that the net deferred tax assets will ultimately be realized, except as noted below. Its conclusion is based on its estimate of future taxable income and the expected timing of temporary difference reversals. The Company has gross state net operating loss carryforwards of approximately $9.9 billion, which expire from 2024 through 2043. The Company’s tax affected federal and state net operating loss and credit carryforwards are approximately less than $1 million and $533 million, respectively. A valuation allowance of approximately $983 million has been recognized for state net operating loss carryforwards, state credit carryforwards and federal and state deferred tax assets that the Company does not expect to be able to realize. With respect to the deferred tax liability pertaining to intangibles, as included above, goodwill purchased in connection with certain of the Company’s business acquisitions is amortizable for income tax reporting purposes. However, for financial reporting purposes, there is no corresponding amortization allowed with respect to such purchased goodwill.

The valuation allowance for federal and state jurisdictions where the Company concluded that the associated deferred tax assets would not be realized increased by $88 million and $66 million, respectively, for the year ended December 31, 2023, and increased by $122 million and decreased by $108 million, respectively, for the year ended December 31, 2022.

The total amount of unrecognized benefit that would affect the effective tax rate, if recognized, was $45 million as of December 31, 2023. A total of $2 million of interest and penalties is included in the amount of the liability for uncertain tax positions at December 31, 2023. It is the Company’s policy to recognize interest and penalties related to unrecognized benefits in its consolidated statements of (loss) income as income tax expense.

It is possible the amount of unrecognized tax benefit could change in the next 12 months as a result of a lapse of the statute of limitations and settlements with taxing authorities; however, the Company does not anticipate the change will have a material impact on the Company’s consolidated results of operations or consolidated financial position.

The following is a tabular reconciliation of the total amount of unrecognized tax benefit for the years ended December 31, 2023, 2022 and 2021 (in millions):

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Unrecognized tax benefit, beginning of year

 

$

50

 

 

$

42

 

 

$

45

 

Gross increases — tax positions in current period

 

 

9

 

 

 

8

 

 

 

5

 

Reductions — tax positions in prior period

 

 

(1

)

 

 

 

 

 

(8

)

Unrecognized tax benefit, end of year

 

$

58

 

 

$

50

 

 

$

42

 

The Company’s income tax return for the 2018 tax year remains under examination by the Internal Revenue Service. The Company believes the result of this examination will not be material to its consolidated results of operations or consolidated financial position. The Company has extended the federal statute of limitations through June 30, 2025 for Community Health Systems, Inc. for the tax period ended December 31, 2018.

Cash paid for income taxes, net of refunds received, was $91 million, $6 million and $4 million during the years ended December 31, 2023, 2022 and 2021, respectively.